Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Controversies in adjuvant and neoadjuvant therapies for breast cancer reviewed
October 6th, 2005
Controversies in adjuvant and neoadjuvant therapies for breast cancer were reviewed in a recent article published in Expert Opinion on Pharmacotherapy. "Initial randomized studies of chemotherapy and endocrine therapy showed that systemic treatments had a substantial impact on the survival of women with early breast cancer," stated scientists in Italy. "The original assumption was that the efficacy of these treatments was limited to those patients presenting with more adverse prognostic features." "Subsequently, meta-analyses of randomized trials revealed that the benefits of chemotherapy and endocrine therapy are not mutually exclusive and...
Source: Women's Health Weekly (2005-10-06)
|
